Oncoinvent ASA Financial Flexibility Index
Oncoinvent ASA financial flexibility index. Oncoinvent ASA (KLDVK) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of Nkr5.76 Million (operating CF Nkr3.64 Million minus capex Nkr2.12 Million) represents 0% of total liabilities (Nkr230.30 Million). Explore KLDVK capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Oncoinvent ASA (2021–2025)
Financial flexibility index of Oncoinvent ASA from 2021 to 2025. Historical Financial Flexibility Index trend for Oncoinvent ASA across 5 annual periods. Check Oncoinvent ASA investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Oncoinvent ASA Financial Flexibility Index by Year (2021–2025)
Oncoinvent ASA financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Oncoinvent ASA. For the full cash flow conversion analysis, see cash efficiency ratio of Oncoinvent ASA.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.04x | Nkr-8.47 Million | Nkr-23.24 Million | Nkr230.30 Million | ▼ -187.0% |
| 2024 | 0.04x | Nkr9.07 Million | Nkr-14.84 Million | Nkr214.71 Million | ▲ +129.2% |
| 2023 | -0.14x | Nkr-20.79 Million | Nkr-40.23 Million | Nkr143.77 Million | ▼ -238.3% |
| 2022 | 0.10x | Nkr12.50 Million | Nkr373.06K | Nkr119.51 Million | ▼ -80.0% |
| 2021 | 0.52x | Nkr31.01 Million | Nkr130.66K | Nkr59.25 Million | — |